How Biosimilars Affect Health Care
Publication
, Journal Article
Furman, RR; Lyman, GH
Published in: CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
2019
Duke Scholars
Published In
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
ISSN
1543-0790
Publication Date
2019
Volume
17
Issue
10
Start / End Page
530 / 530
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Furman, R. R., & Lyman, G. H. (2019). How Biosimilars Affect Health Care. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 17(10), 530–530.
Furman, Richard R., and Gary H. Lyman. “How Biosimilars Affect Health Care.” CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY 17, no. 10 (2019): 530–530.
Furman RR, Lyman GH. How Biosimilars Affect Health Care. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY. 2019;17(10):530–530.
Furman, Richard R., and Gary H. Lyman. “How Biosimilars Affect Health Care.” CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, vol. 17, no. 10, 2019, pp. 530–530.
Furman RR, Lyman GH. How Biosimilars Affect Health Care. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY. 2019;17(10):530–530.
Published In
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
ISSN
1543-0790
Publication Date
2019
Volume
17
Issue
10
Start / End Page
530 / 530
Related Subject Headings
- Oncology & Carcinogenesis